Pharmacoeconomic Analysis of Vaccination in Developed Versus Developing Countries

Abstract

Pharmacoeconomic analyses are performed preferentially in developed countries where there is an imperative to obtain “value for money” and to achieve cost-effectiveness. Such analyses are performed in low-income/developing countries and middle-income countries, partly to save scarce resources but also to improve the overall economic outlook, promote productivity gains, and foster further investment in vaccination. Analyses appear to be performed preferentially for therapeutic products as opposed to vaccines, but this may change as the impact of applying the results of pharmacoeconomic analyses of vaccines are measured and quantified. © 2014 by Pediatric Infectious Diseases Society.